Price $8.86 |
Market Cap
250.1M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
10.65
|
P/S
-
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-1.4K
|
FCF
-0.3
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-156.80%
|
ROI
-
|
|
ROA
-76.60%
|
EPS Growth
-
|
Current Ratio
0.2
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Advanz Pharma Corp Ltd (CXRXF) | $16.70 | - | - | 826.6M | Strong Buy |
| Kaya Holdings Inc (KAYS) | $0.41 | - | - | 6.8M | Strong Buy |
| Aravive Inc (ARAV) | $4.75 | - | - | 110.3M | Strong Buy |
| NuVasive, Inc. (NUVA) | $68.32 | - | - | 3.68B | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $23.14 | - | - | 923.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
